Peningkatan Kesadaran Kesehatan Metabolik dan Skrining Kolesterol Untuk Mencegah Penyakit Kardiovaskular pada Usia Produktif
DOI:
https://doi.org/10.59603/jpmnt.v3i3.969Keywords:
Cholesterol, Dyslipidemia, Early Detection, ScreeningAbstract
Dyslipidemia is a major public health risk factor for cardiovascular disease. This condition is characterized by abnormal blood lipid levels, including LDL cholesterol, HDL cholesterol, and triglycerides. Hypercholesterolemia is often asymptomatic, resulting in many undiagnosed cases until cardiovascular complications occur. The rising prevalence of dyslipidemia, especially in low- and middle-income countries, underscores the importance of screening and prevention to reduce the risk of long-term complications. This community service activity involved 49 adult participants in Danau Sunter, North Jakarta, with cholesterol and HDL level screening conducted through blood tests by trained health workers. The results showed that 29 participants (59.18%) had abnormal cholesterol levels, and 22 participants (44.9%) had low to very low HDL levels. Adopting a healthy lifestyle, including a balanced diet, increased physical activity, and controlling other risk factors such as smoking and alcohol consumption, can help lower cholesterol levels. Routine cholesterol screening is highly effective for early detection of dyslipidemia risk, enabling timely preventive interventions to reduce cardiovascular morbidity and mortality.
References
Andriyas, E., & Hussain, I. (2023). Dyslipidemia: Classification, Etiology and Management-A Systemic Review. International Journal of Pharmaceutical Research and Applications, 8(6), 241–244. https://doi.org/10.35629/7781-0806241244
Dharmayat, K., Vallejo-Vaz, A., Stevens, C., Elshorbagy, A., Brandts, J., Lyons, A., Catapano, A., Freiberger, T., Hovingh, G. K., Mata, P., Santos, R., Soran, H., Watts, G., Raal, F., & Ray, K. (2023). How are children and adolescents with familial hypercholesterolaemia detected globally? Analysis from the FHSC registry on over 11,800 participants from 48 countries. Atherosclerosis, 379, S25–S26. https://doi.org/10.1016/j.atherosclerosis.2023.06.950
Khoury, M., Bigras, J.-L., Cummings, E. A., Harris, K. C., Hegele, R. A., Henderson, M., Morrison, K. M., St-Pierre, J., Wong, P. D., & McCrindle, B. W. (2022). The Detection, Evaluation, and Management of Dyslipidemia in Children and Adolescents: A Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Clinical Practice Update. Canadian Journal of Cardiology, 38(8), 1168–1179. https://doi.org/10.1016/j.cjca.2022.05.002
Kosmas, C. E., Rodriguez Polanco, S., Bousvarou, M. D., Papakonstantinou, E. J., Peña Genao, E., Guzman, E., & Kostara, C. E. (2023). The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease. Diagnostics (Basel, Switzerland), 13(5). https://doi.org/10.3390/diagnostics13050929
Mahboob, M. (2024). Addressing the Public Health Crisis of Dyslipidemia. The Journal of Cardiovascular Diseases, 19(4). https://doi.org/10.55958/jcvd.v19i4.163
Mosca, S., Araújo, G., Costa, V., Correia, J., Bandeira, A., Martins, E., Mansilha, H., Tavares, M., & Coelho, M. P. (2022). Dyslipidemia Diagnosis and Treatment: Risk Stratification in Children and Adolescents. Journal of Nutrition and Metabolism, 2022, 1–10. https://doi.org/10.1155/2022/4782344
Opoku, S., Gan, Y., Yobo, E. A., Tenkorang-Twum, D., Yue, W., Wang, Z., & Lu, Z. (2021). Awareness, treatment, control, and determinants of dyslipidemia among adults in China. Scientific Reports, 11(1), 10056. https://doi.org/10.1038/s41598-021-89401-2
Pappan, N., & Rehman, A. (2024). Dyslipidemia. In StatPearls. http://www.ncbi.nlm.nih.gov/pubmed/8185133
Pirillo, A., Casula, M., Olmastroni, E., Norata, G. D., & Catapano, A. L. (2021). Global epidemiology of dyslipidaemias. Nature Reviews. Cardiology, 18(10), 689–700. https://doi.org/10.1038/s41569-021-00541-4
Ruslim, D., Radiologi, B., Destra, E., Kurniawan, J., & Firmansyah, Y. (2023). Pengaruh Kadar High Density Lipoprotein (HDL) dan Usia terhadap Kejadian Peripheral Arterial Disease (PAD). Termometer: Jurnal Ilmiah Ilmu Kesehatan Dan Kedokteran, 1(3), 180–190. https://doi.org/10.55606/TERMOMETER.V1I3.2059
Streja, E., & Feingold, K. R. (2024). Evaluation and Treatment of Dyslipidemia in the Elderly. In Endotext. http://www.ncbi.nlm.nih.gov/pubmed/23500290
Thongtang, N., Sukmawan, R., Llanes, E. J. B., & Lee, Z.-V. (2022). Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices. Preventive Medicine Reports, 27, 101819. https://doi.org/10.1016/j.pmedr.2022.101819
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jurnal Pengabdian Masyarakat Nian Tana
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
